Literature DB >> 2297253

Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate.

R H Zax1, S J Hodge, J P Callen.   

Abstract

Data from experimentally induced cutaneous vasculitis have suggested that the inflammatory infiltrate is dynamic. In contrast, data from humans with cutaneous vasculitis have suggested that two distinct patterns of cellular infiltrate exist, a mononuclear-predominant and a neutrophilic-predominant type. There are little data regarding the temporal evolution of spontaneously occurring cutaneous vasculitis in humans. A patient with a cutaneous leukocytoclastic vasculitis manifest as palpable purpura had four lesions encircled on the day of presentation. Biopsies of these lesions were obtained sequentially at 0, 24, 48, and 120 hours. The histopathologic specimens were graded without knowledge of the timing of the biopsy. The character of the infiltrate progressively changed from a neutrophilic-predominant to a mononuclear-predominant infiltrate supporting the theory of a dynamic process in cutaneous vasculitis. The previous reports that suggest that there are two distinct inflammatory cell types may be the result of performing the biopsy at one point in time during this transitory process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297253     DOI: 10.1001/archderm.126.1.69

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  11 in total

1.  Ileitis terminalis in a patient with Henoch-Schönlein purpura.

Authors:  N Ortego-Centeno; J L Callejas-Rubio; J G López-Mañas; E Troncoso-García; J de la Higuera Torres-Puchol
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Leukocytoclastic vasculitis drug reaction to certolizumab pegol.

Authors:  Meghan Woody; Donald Warren; Laura Speck; Julie Jackson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 3.  Cutaneous manifestations in systemic vasculitis.

Authors:  I Decleva; A V Marzano; M Barbareschi; E Berti
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.

Authors:  H M Markusse; M Schoonbrood; M Oudkerk; S C Henzen-Logmans
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

5.  Blocking von Willebrand factor for treatment of cutaneous inflammation.

Authors:  Carina Hillgruber; Annika K Steingräber; Birgit Pöppelmann; Cécile V Denis; Jerry Ware; Dietmar Vestweber; Bernhard Nieswandt; Stefan W Schneider; Tobias Goerge
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

Review 6.  Optimal treatment of venous (stasis) ulcers in elderly patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

7.  Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis.

Authors:  N P Burrows; F A Molina; G Terenghi; P K Clark; D O Haskard; J M Polak; R R Jones
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

8.  Rituximab therapy for severe cutaneous leukocytoclastic angiitis refractory to corticosteroids, cellcept and cyclophosphamide.

Authors:  Kamel El-Reshaid; John Patrick Madda
Journal:  Case Rep Dermatol       Date:  2013-04-16

9.  Hypersensitivity vasculitis induced by cefoperazone/sulbactam.

Authors:  Ismail Islek; Sancar Baris; Ali O Katranci; Ender Ariturk; Nuran Gurses
Journal:  Ann Clin Microbiol Antimicrob       Date:  2003-01-03       Impact factor: 3.944

10.  A case of Henoch-Schönlein purpura in disseminated tuberculosis.

Authors:  B G Han; S O Choi; S J Shin; H Y Kim; S H Jung; K H Lee
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.